Ironwood Pharmaceuticals (IRWD) Other Operating Expenses (2012 - 2026)

Ironwood Pharmaceuticals has disclosed Other Operating Expenses across 13 years of filings, most recently posting -$40000.0 for Q1 2026.

• Other Operating Expenses for Q1 2026 came in at -$40000.0, down 100.22% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.7 million (down 92.0% YoY), and the FY2025 annual result was $20.3 million, up 681.22% from the prior year.
• Other Operating Expenses came in at -$40000.0 for Q1 2026 at Ironwood Pharmaceuticals, up from -$252000.0 in the prior quarter.
• In the past five years, Other Operating Expenses ranged from a high of $1.1 billion in Q2 2023 to a low of -$252000.0 in Q4 2025.
• The 4-year median for Other Operating Expenses is $1.3 million (2024), against an average of $97.1 million.
• Peak annual rise in Other Operating Expenses reached 13650.0% in 2025, while the deepest fall reached 445.21% in 2025.
• Ironwood Pharmaceuticals' Other Operating Expenses stood at $5.6 million in 2023, then sank by 98.7% to $73000.0 in 2024, then sank by 445.21% to -$252000.0 in 2025, then soared by 84.13% to -$40000.0 in 2026.
• The last three Other Operating Expenses figures came in at -$40000.0 (Q1 2026), -$252000.0 (Q4 2025), and $2.2 million (Q3 2025), per Business Quant data.